{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:42:51Z","timestamp":1783734171121,"version":"3.55.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006988","name":"John S. Dunn Foundation","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/100006988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00395-019-0743-0","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T09:04:41Z","timestamp":1565082281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3\/ASC inflammasome"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7653-6328","authenticated-orcid":false,"given":"Yochai","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"743_CR1","unstructured":"Diabetes Statistics In: American Diabetes Association. http:\/\/www.diabetes.org\/diabetes-statistics.jsp"},{"key":"743_CR2","unstructured":"(2008) Number of people with diabetes continues to increase. In: Centers for disease control and prevention. Division of diabetes translation, National Center for Chronic Disease Prevention and Health Promotion. https:\/\/www.cdc.gov\/diabetes\/index.html"},{"key":"743_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.lfs.2015.11.026","volume":"159","author":"M Abdelsaid","year":"2016","unstructured":"Abdelsaid M, Williams R, Hardigan T, Ergul A (2016) Linagliptin attenuates diabetes-induced cerebral pathological neovascularization in a blood glucose-independent manner: potential role of ET-1. Life Sci 159:83\u201389. https:\/\/doi.org\/10.1016\/j.lfs.2015.11.026","journal-title":"Life Sci"},{"key":"743_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","volume":"20","author":"L Agostini","year":"2004","unstructured":"Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle\u2013Wells autoinflammatory disorder. Immunity 20:319\u2013325. https:\/\/doi.org\/10.1016\/S1074-7613(04)00046-9","journal-title":"Immunity"},{"key":"743_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1365-2567.2002.01401.x","volume":"106","author":"H An","year":"2002","unstructured":"An H, Yu Y, Zhang M, Xu H, Qi R, Yan X, Liu S, Wang W, Guo Z, Guo J, Qin Z, Cao X (2002) Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106:38\u201345. https:\/\/doi.org\/10.1046\/j.1365-2567.2002.01401.x","journal-title":"Immunology"},{"key":"743_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12933-017-0544-4","volume":"16","author":"AR Aroor","year":"2017","unstructured":"Aroor AR, Habibi J, Kandikattu HK, Garro-Kacher M, Barron B, Chen D, Hayden MR, Whaley-Connell A, Bender SB, Klein T, Padilla J, Sowers JR, Chandrasekar B, DeMarco VG (2017) Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice. Cardiovasc Diabetol 16:61. https:\/\/doi.org\/10.1186\/s12933-017-0544-4","journal-title":"Cardiovasc Diabetol"},{"key":"743_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/FJC.0000000000000531","volume":"70","author":"S Baba","year":"2017","unstructured":"Baba S, Iwasa M, Higashi K, Minatoguchi S, Yamada Y, Kanamori H, Kawasaki M, Nishigaki K, Minatoguchi S (2017) Antidiabetic drug alogliptin protects the heart against ischemia\u2013reperfusion injury through GLP-1 receptor-dependent and receptor-independent pathways involving nitric oxide production in rabbits. J Cardiovasc Pharmacol 70:382\u2013389. https:\/\/doi.org\/10.1097\/FJC.0000000000000531","journal-title":"J Cardiovasc Pharmacol"},{"key":"743_CR8","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1210\/en.2018-00004","volume":"159","author":"LL Baggio","year":"2018","unstructured":"Baggio LL, Yusta B, Mulvihill EE, Cao X, Streutker CJ, Butany J, Cappola TP, Margulies KB, Drucker DJ (2018) GLP-1 receptor expression within the human heart. Endocrinology 159:1570\u20131584. https:\/\/doi.org\/10.1210\/en.2018-00004","journal-title":"Endocrinology"},{"key":"743_CR9","doi-asserted-by":"publisher","first-page":"23086","DOI":"10.3390\/ijms141123086","volume":"14","author":"MH Bao","year":"2013","unstructured":"Bao MH, Feng X, Zhang YW, Lou XY, Cheng Y, Zhou HH (2013) Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int J Mol Sci 14:23086\u201323102. https:\/\/doi.org\/10.3390\/ijms141123086","journal-title":"Int J Mol Sci"},{"key":"743_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijcard.2012.09.204","volume":"167","author":"FJ Bernink","year":"2013","unstructured":"Bernink FJ, Timmers L, Diamant M, Scholte M, Beek AM, Kamp O, Marques KM, Denham RN, Chen WJ, Doevendans PA, van Rossum AC, van Royen N, Horrevoets AJ, Appelman Y (2013) Effect of additional treatment with EXenatide in patients with an acute myocardial infarction: the EXAMI study. Int J Cardiol 167:289\u2013290. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.204","journal-title":"Int J Cardiol"},{"key":"743_CR11","doi-asserted-by":"publisher","first-page":"e000227","DOI":"10.1136\/bmjdrc-2016-000227","volume":"4","author":"Y Birnbaum","year":"2016","unstructured":"Birnbaum Y, Bajaj M, Qian J, Ye Y (2016) Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3\/ASC inflammasome. BMJ Open Diabetes Res Care 4:e000227. https:\/\/doi.org\/10.1136\/bmjdrc-2016-000227","journal-title":"BMJ Open Diabetes Res Care"},{"key":"743_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10557-012-6409-x","volume":"26","author":"Y Birnbaum","year":"2012","unstructured":"Birnbaum Y, Castillo AC, Qian J, Ling S, Ye H, Perez-Polo JR, Bajaj M, Ye Y (2012) Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus. Cardiovasc Drugs Ther 26:445\u2013456. https:\/\/doi.org\/10.1007\/s10557-012-6409-x","journal-title":"Cardiovasc Drugs Ther"},{"key":"743_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00395-011-0162-3","volume":"106","author":"Y Birnbaum","year":"2011","unstructured":"Birnbaum Y, Long B, Qian J, Perez-Polo JR, Ye Y (2011) Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-gamma-independent manner. Basic Res Cardiol 106:431\u2013446. https:\/\/doi.org\/10.1007\/s00395-011-0162-3","journal-title":"Basic Res Cardiol"},{"key":"743_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","volume":"113","author":"HE Botker","year":"2018","unstructured":"Botker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femmino S, Garcia-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhauser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schluter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G (2018) Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol 113:39. https:\/\/doi.org\/10.1007\/s00395-018-0696-8","journal-title":"Basic Res Cardiol"},{"key":"743_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molimm.2016.05.001","volume":"74","author":"P Boza","year":"2016","unstructured":"Boza P, Ayala P, Vivar R, Humeres C, Caceres FT, Munoz C, Garcia L, Hermoso MA, Diaz-Araya G (2016) Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1beta synthesis, secretion, and degradation. Mol Immunol 74:96\u2013105. https:\/\/doi.org\/10.1016\/j.molimm.2016.05.001","journal-title":"Mol Immunol"},{"key":"743_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbrc.2018.03.142","volume":"499","author":"A Chen","year":"2018","unstructured":"Chen A, Chen Z, Xia Y, Lu D, Yang X, Sun A, Zou Y, Qian J, Ge J (2018) Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1\/NOX4\/ROS pathway in H9c2 cells. Biochem Biophys Res Commun 499:267\u2013272. https:\/\/doi.org\/10.1016\/j.bbrc.2018.03.142","journal-title":"Biochem Biophys Res Commun"},{"key":"743_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/1479164116679081","volume":"14","author":"Y Chen","year":"2017","unstructured":"Chen Y, Chen H, Birnbaum Y, Nanhwan MK, Bajaj M, Ye Y, Qian J (2017) Aleglitazar, a dual peroxisome proliferator-activated receptor-alpha and -gamma agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia. Diabetes Vasc Dis Res 14:152\u2013162. https:\/\/doi.org\/10.1177\/1479164116679081","journal-title":"Diabetes Vasc Dis Res"},{"key":"743_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/1753-0407.12258","volume":"8","author":"KA Connelly","year":"2016","unstructured":"Connelly KA, Advani A, Zhang Y, Advani SL, Kabir G, Abadeh A, Desjardins JF, Mitchell M, Thai K, Gilbert RE (2016) Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: role of stromal cell-derived factor-1alpha. J Diabetes 8:63\u201375. https:\/\/doi.org\/10.1111\/1753-0407.12258","journal-title":"J Diabetes"},{"key":"743_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10557-014-6539-4","volume":"28","author":"Y Dai","year":"2014","unstructured":"Dai Y, Dai D, Wang X, Ding Z, Mehta JL (2014) DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway. Cardiovasc Drugs Ther 28:425\u2013432. https:\/\/doi.org\/10.1007\/s10557-014-6539-4","journal-title":"Cardiovasc Drugs Ther"},{"key":"743_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1161\/CIRCULATIONAHA.107.188629","volume":"117","author":"P Deedwania","year":"2008","unstructured":"Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610\u20131619. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.188629","journal-title":"Circulation"},{"key":"743_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.gde.2008.07.015","volume":"18","author":"S Dias","year":"2008","unstructured":"Dias S, Xu W, McGregor S, Kee B (2008) Transcriptional regulation of lymphocyte development. Curr Opin Genet Dev 18:441\u2013448. https:\/\/doi.org\/10.1016\/j.gde.2008.07.015","journal-title":"Curr Opin Genet Dev"},{"key":"743_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2337\/db12-1115","volume":"62","author":"VD Dixit","year":"2013","unstructured":"Dixit VD (2013) Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant? Diabetes 62:22\u201324. https:\/\/doi.org\/10.2337\/db12-1115","journal-title":"Diabetes"},{"key":"743_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98\u2013107. https:\/\/doi.org\/10.1038\/nri2925","journal-title":"Nat Rev Immunol"},{"key":"743_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.thromres.2017.09.016","volume":"159","author":"A Dong","year":"2017","unstructured":"Dong A, Mueller P, Yang F, Yang L, Morris A, Smyth SS (2017) Direct thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice. Thromb Res 159:58\u201364. https:\/\/doi.org\/10.1016\/j.thromres.2017.09.016","journal-title":"Thromb Res"},{"key":"743_CR25","doi-asserted-by":"publisher","first-page":"H732","DOI":"10.1152\/ajpheart.00948.2011","volume":"303","author":"B Dong","year":"2012","unstructured":"Dong B, Qi D, Yang L, Huang Y, Xiao X, Tai N, Wen L, Wong FS (2012) TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes. Am J Physiol Heart Circ Physiol 303:H732\u2013H742. https:\/\/doi.org\/10.1152\/ajpheart.00948.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"743_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3:153\u2013165. https:\/\/doi.org\/10.1016\/j.cmet.2006.01.004","journal-title":"Cell Metab"},{"key":"743_CR27","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","volume":"368","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696\u20131705. https:\/\/doi.org\/10.1016\/S0140-6736(06)69705-5","journal-title":"Lancet"},{"key":"743_CR28","doi-asserted-by":"publisher","first-page":"C270","DOI":"10.1152\/ajpcell.00194.2015","volume":"310","author":"J Du","year":"2016","unstructured":"Du J, Zhang L, Wang Z, Yano N, Zhao YT, Wei L, Dubielecka-Szczerba P, Liu PY, Zhuang S, Qin G, Zhao TC (2016) Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts. Am J Physiol Cell Physiol 310:C270\u2013C283. https:\/\/doi.org\/10.1152\/ajpcell.00194.2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"743_CR29","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1210\/en.2012-1855","volume":"154","author":"N Ervinna","year":"2013","unstructured":"Ervinna N, Mita T, Yasunari E, Azuma K, Tanaka R, Fujimura S, Sukmawati D, Nomiyama T, Kanazawa A, Kawamori R, Fujitani Y, Watada H (2013) Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology 154:1260\u20131270. https:\/\/doi.org\/10.1210\/en.2012-1855","journal-title":"Endocrinology"},{"key":"743_CR30","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","volume":"106","author":"K Esposito","year":"2002","unstructured":"Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067\u20132072. https:\/\/doi.org\/10.1161\/01.CIR.0000034509.14906.AE","journal-title":"Circulation"},{"key":"743_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.vph.2011.05.001","volume":"55","author":"GP Fadini","year":"2011","unstructured":"Fadini GP, Avogaro A (2011) Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. Vasc Pharmacol 55:10\u201316. https:\/\/doi.org\/10.1016\/j.vph.2011.05.001","journal-title":"Vasc Pharmacol"},{"key":"743_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fimmu.2013.00050","volume":"4","author":"RW Grant","year":"2013","unstructured":"Grant RW, Dixit VD (2013) Mechanisms of disease: inflammasome activation and the development of type 2 diabetes. Front Immunol 4:50. https:\/\/doi.org\/10.3389\/fimmu.2013.00050","journal-title":"Front Immunol"},{"key":"743_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/nejmoa1501352","volume":"373","author":"JB Green","year":"2015","unstructured":"Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR, Group TS (2015) Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med 373:232\u2013242. https:\/\/doi.org\/10.1056\/nejmoa1501352","journal-title":"N Engl J Med"},{"key":"743_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229\u2013234. https:\/\/doi.org\/10.1056\/NEJM199807233390404","journal-title":"N Engl J Med"},{"key":"743_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.it.2010.01.002","volume":"31","author":"G Hajishengallis","year":"2010","unstructured":"Hajishengallis G, Lambris JD (2010) Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31:154\u2013163. https:\/\/doi.org\/10.1016\/j.it.2010.01.002","journal-title":"Trends Immunol"},{"key":"743_CR36","first-page":"1285","volume":"19","author":"E Hamaguchi","year":"2015","unstructured":"Hamaguchi E, Tanaka K, Tsutsumi R, Sakai Y, Fukuta K, Kasai A, Tsutsumi YM (2015) Exendin-4, glucagon-like peptide-1 receptor agonist, enhances isoflurane-induced preconditioning against myocardial infarction via caveolin-3 expression. Eur Rev Med Pharmacol Sci 19:1285\u20131290","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"743_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00395-016-0599-5","volume":"112","author":"J Han","year":"2017","unstructured":"Han J, Zou C, Mei L, Zhang Y, Qian Y, You S, Pan Y, Xu Z, Bai B, Huang W, Liang G (2017) MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4\/NF-kappaB signaling pathway. Basic Res Cardiol 112:9. https:\/\/doi.org\/10.1007\/s00395-016-0599-5","journal-title":"Basic Res Cardiol"},{"key":"743_CR38","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","volume":"120","author":"G Heusch","year":"2017","unstructured":"Heusch G (2017) Critical issues for the translation of cardioprotection. Circ Res 120:1477\u20131486. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310820","journal-title":"Circ Res"},{"key":"743_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejphar.2012.11.057","volume":"699","author":"Y Hirata","year":"2013","unstructured":"Hirata Y, Kurobe H, Nishio C, Tanaka K, Fukuda D, Uematsu E, Nishimoto S, Soeki T, Harada N, Sakaue H, Kitagawa T, Shimabukuro M, Nakaya Y, Sata M (2013) Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury. Eur J Pharmacol 699:106\u2013111. https:\/\/doi.org\/10.1016\/j.ejphar.2012.11.057","journal-title":"Eur J Pharmacol"},{"key":"743_CR40","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00109-016-1403-6","volume":"94","author":"LC Ho","year":"2016","unstructured":"Ho LC, Sung JM, Shen YT, Jheng HF, Chen SH, Tsai PJ, Tsai YS (2016) Egr-1 deficiency protects from renal inflammation and fibrosis. J Mol Med (Berl) 94:933\u2013942. https:\/\/doi.org\/10.1007\/s00109-016-1403-6","journal-title":"J Mol Med (Berl)"},{"key":"743_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijcard.2011.12.007","volume":"167","author":"B Hocher","year":"2013","unstructured":"Hocher B, Sharkovska Y, Mark M, Klein T, Pfab T (2013) The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia\/reperfusion in rats. Int J Cardiol 167:87\u201393. https:\/\/doi.org\/10.1016\/j.ijcard.2011.12.007","journal-title":"Int J Cardiol"},{"key":"743_CR42","doi-asserted-by":"publisher","first-page":"600","DOI":"10.5603\/CJ.2013.0159","volume":"20","author":"G Hu","year":"2013","unstructured":"Hu G, Zhang Y, Jiang H, Hu X (2013) Exendin-4 attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression. Cardiol J 20:600\u2013604. https:\/\/doi.org\/10.5603\/CJ.2013.0159","journal-title":"Cardiol J"},{"key":"743_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000227809","volume":"24","author":"Z Huang","year":"2009","unstructured":"Huang Z, Li H, Guo F, Jia Q, Zhang Y, Liu X, Shi G (2009) Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia\/reperfusion injury in rats. Cell Physiol Biochem 24:17\u201324. https:\/\/doi.org\/10.1159\/000227809","journal-title":"Cell Physiol Biochem"},{"key":"743_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.lfs.2018.06.005","volume":"207","author":"Y Hui","year":"2018","unstructured":"Hui Y, Yin Y (2018) MicroRNA-145 attenuates high glucose-induced oxidative stress and inflammation in retinal endothelial cells through regulating TLR4\/NF-kappaB signaling. Life Sci 207:212\u2013218. https:\/\/doi.org\/10.1016\/j.lfs.2018.06.005","journal-title":"Life Sci"},{"key":"743_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00395-016-0537-6","volume":"111","author":"J Inserte","year":"2016","unstructured":"Inserte J, Cardona M, Poncelas-Nozal M, Hernando V, Vilardosa U, Aluja D, Parra VM, Sanchis D, Garcia-Dorado D (2016) Studies on the role of apoptosis after transient myocardial ischemia: genetic deletion of the executioner caspases-3 and -7 does not limit infarct size and ventricular remodeling. Basic Res Cardiol 111:18. https:\/\/doi.org\/10.1007\/s00395-016-0537-6","journal-title":"Basic Res Cardiol"},{"key":"743_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","volume":"49","author":"K Kaji","year":"2014","unstructured":"Kaji K, Yoshiji H, Ikenaka Y, Noguchi R, Aihara Y, Douhara A, Moriya K, Kawaratani H, Shirai Y, Yoshii J, Yanase K, Kitade M, Namisaki T, Fukui H (2014) Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J Gastroenterol 49:481\u2013491. https:\/\/doi.org\/10.1007\/s00535-013-0783-4","journal-title":"J Gastroenterol"},{"key":"743_CR47","doi-asserted-by":"publisher","first-page":"H2097","DOI":"10.1152\/ajpheart.2001.281.5.H2097","volume":"281","author":"JR Kersten","year":"2001","unstructured":"Kersten JR, Toller WG, Tessmer JP, Pagel PS, Warltier DC (2001) Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol 281:H2097\u2013H2104. https:\/\/doi.org\/10.1152\/ajpheart.2001.281.5.H2097","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"743_CR48","doi-asserted-by":"publisher","first-page":"H1198","DOI":"10.1152\/ajpheart.00915.2009","volume":"298","author":"KT Keyes","year":"2010","unstructured":"Keyes KT, Xu J, Long B, Zhang C, Hu Z, Ye Y (2010) Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am J Physiol Heart Circ Physiol 298:H1198\u2013H1208. https:\/\/doi.org\/10.1152\/ajpheart.00915.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"743_CR49","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/jcb.21783","volume":"104","author":"MJ Kim","year":"2008","unstructured":"Kim MJ, Kang JH, Chang SY, Jang HJ, Ryu GR, Ko SH, Jeong IK, Kim MS, Jo YH (2008) Exendin-4 induction of Egr-1 expression in INS-1 beta-cells: interaction of SRF, not YY1, with SRE site of rat Egr-1 promoter. J Cell Biochem 104:2261\u20132271. https:\/\/doi.org\/10.1002\/jcb.21783","journal-title":"J Cell Biochem"},{"key":"743_CR50","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.2337\/db09-0626","volume":"58","author":"JA Koehler","year":"2009","unstructured":"Koehler JA, Baggio LL, Lamont BJ, Ali S, Drucker DJ (2009) Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice. Diabetes 58:2148\u20132161. https:\/\/doi.org\/10.2337\/db09-0626","journal-title":"Diabetes"},{"key":"743_CR51","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1007\/s00125-018-4701-4","volume":"61","author":"M Kolibabka","year":"2018","unstructured":"Kolibabka M, Dietrich N, Klein T, Hammes HP (2018) Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy. Diabetologia 61:2412\u20132421. https:\/\/doi.org\/10.1007\/s00125-018-4701-4","journal-title":"Diabetologia"},{"key":"743_CR52","doi-asserted-by":"publisher","first-page":"e54518","DOI":"10.1371\/journal.pone.0054518","volume":"8","author":"HC Ku","year":"2013","unstructured":"Ku HC, Chen WP, Su MJ (2013) DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes. PLoS One 8:e54518. https:\/\/doi.org\/10.1371\/journal.pone.0054518","journal-title":"PLoS One"},{"key":"743_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.peptides.2017.04.009","volume":"93","author":"K Kyhl","year":"2017","unstructured":"Kyhl K, Lonborg J, Hartmann B, Kissow H, Poulsen SS, Ali HE, Kjaer A, Dela F, Engstrom T, Treiman M (2017) Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction. Peptides 93:1\u201312. https:\/\/doi.org\/10.1016\/j.peptides.2017.04.009","journal-title":"Peptides"},{"key":"743_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2009.03.019","volume":"47","author":"S Lecour","year":"2009","unstructured":"Lecour S (2009) Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol 47:32\u201340. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.03.019","journal-title":"J Mol Cell Cardiol"},{"key":"743_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.metabol.2015.10.002","volume":"65","author":"DS Lee","year":"2016","unstructured":"Lee DS, Lee ES, Alam MM, Jang JH, Lee HS, Oh H, Kim YC, Manzoor Z, Koh YS, Kang DG, Lee DH (2016) Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate. Metabolism 65:89\u2013101. https:\/\/doi.org\/10.1016\/j.metabol.2015.10.002","journal-title":"Metabolism"},{"key":"743_CR56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","volume":"62","author":"HM Lee","year":"2013","unstructured":"Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK (2013) Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62:194\u2013204. https:\/\/doi.org\/10.2337\/db12-0420","journal-title":"Diabetes"},{"key":"743_CR57","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.3892\/etm.2016.3255","volume":"11","author":"CH Lin","year":"2016","unstructured":"Lin CH, Lin CC (2016) Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-kappaB pathway inhibition. Exp Ther Med 11:2609\u20132615. https:\/\/doi.org\/10.3892\/etm.2016.3255","journal-title":"Exp Ther Med"},{"key":"743_CR58","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejcb.2014.05.001","volume":"93","author":"K Lin","year":"2014","unstructured":"Lin K, Fang S, Cai B, Huang X, Zhang X, Lu Y, Zhang W, Wei E (2014) ERK\/Egr-1 signaling pathway is involved in CysLT2 receptor-mediated IL-8 production in HEK293 cells. Eur J Cell Biol 93:278\u2013288. https:\/\/doi.org\/10.1016\/j.ejcb.2014.05.001","journal-title":"Eur J Cell Biol"},{"key":"743_CR59","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 314:H812\u2013H838. https:\/\/doi.org\/10.1152\/ajpheart.00335.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"743_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00395-017-0663-9","volume":"113","author":"D Liu","year":"2018","unstructured":"Liu D, Zeng X, Li X, Mehta JL, Wang X (2018) Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases. Basic Res Cardiol 113:5. https:\/\/doi.org\/10.1007\/s00395-017-0663-9","journal-title":"Basic Res Cardiol"},{"key":"743_CR61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCINTERVENTIONS.112.968388","volume":"5","author":"J Lonborg","year":"2012","unstructured":"Lonborg J, Kelbaek H, Vejlstrup N, Botker HE, Kim WY, Holmvang L, Jorgensen E, Helqvist S, Saunamaki K, Terkelsen CJ, Schoos MM, Kober L, Clemmensen P, Treiman M, Engstrom T (2012) Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia. Circ Cardiovasc Interv 5:288\u2013295. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.112.968388","journal-title":"Circ Cardiovasc Interv"},{"key":"743_CR62","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","volume":"33","author":"J Lonborg","year":"2012","unstructured":"Lonborg J, Vejlstrup N, Kelbaek H, Botker HE, Kim WY, Mathiasen AB, Jorgensen E, Helqvist S, Saunamaki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Kober L, Treiman M, Holst JJ, Engstrom T (2012) Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J 33:1491\u20131499. https:\/\/doi.org\/10.1093\/eurheartj\/ehr309","journal-title":"Eur Heart J"},{"key":"743_CR63","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/1479164115570301","volume":"12","author":"N Marx","year":"2015","unstructured":"Marx N, Rosenstock J, Kahn SE, Zinman B, Kastelein JJ, Lachin JM, Espeland MA, Bluhmki E, Mattheus M, Ryckaert B, Patel S, Johansen OE, Woerle HJ (2015) Design and baseline characteristics of the CARdiovascular outcome trial of LINAgliptin versus glimepiride in type 2 diabetes (CAROLINA(R)). Diabetes Vasc Dis Res 12:164\u2013174. https:\/\/doi.org\/10.1177\/1479164115570301","journal-title":"Diabetes Vasc Dis Res"},{"issue":"10","key":"743_CR64","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"Seth L Masters","year":"2010","unstructured":"Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nunez G, Yodoi J, Kahn SE, Lavelle EC, O\u2019Neill LA (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11:897\u2013904. https:\/\/doi.org\/10.1038\/ni.1935","journal-title":"Nature Immunology"},{"key":"743_CR65","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2337\/diabetes.45.7.954","volume":"45","author":"M Morohoshi","year":"1996","unstructured":"Morohoshi M, Fujisawa K, Uchimura I, Numano F (1996) Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45:954\u2013959. https:\/\/doi.org\/10.2337\/diabetes.45.7.954","journal-title":"Diabetes"},{"key":"743_CR66","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ijcard.2016.11.198","volume":"228","author":"H Mudaliar","year":"2017","unstructured":"Mudaliar H, Rayner B, Billah M, Kapoor N, Lay W, Dona A, Bhindi R (2017) Remote ischemic preconditioning attenuates EGR-1 expression following myocardial ischemia reperfusion injury through activation of the JAK-STAT pathway. Int J Cardiol 228:729\u2013741. https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.198","journal-title":"Int J Cardiol"},{"key":"743_CR67","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2337\/diacare.24.8.1422","volume":"24","author":"KJ Mukamal","year":"2001","unstructured":"Mukamal KJ, Nesto RW, Cohen MC, Muller JE, Maclure M, Sherwood JB, Mittleman MA (2001) Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 24:1422\u20131427. https:\/\/doi.org\/10.2337\/diacare.24.8.1422","journal-title":"Diabetes Care"},{"key":"743_CR68","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2337\/db08-1193","volume":"58","author":"MH Noyan-Ashraf","year":"2009","unstructured":"Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ (2009) GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 58:975\u2013983. https:\/\/doi.org\/10.2337\/db08-1193","journal-title":"Diabetes"},{"key":"743_CR69","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1161\/hq0801.093667","volume":"21","author":"A Pandolfi","year":"2001","unstructured":"Pandolfi A, Cetrullo D, Polishuck R, Alberta MM, Calafiore A, Pellegrini G, Vitacolonna E, Capani F, Consoli A (2001) Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol 21:1378\u20131382. https:\/\/doi.org\/10.1161\/hq0801.093667","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"743_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s005920170016","volume":"38","author":"A Pandolfi","year":"2001","unstructured":"Pandolfi A, Giaccari A, Cilli C, Alberta MM, Morviducci L, De Filippis EA, Buongiorno A, Pellegrini G, Capani F, Consoli A (2001) Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 38:71\u201376. https:\/\/doi.org\/10.1007\/s005920170016","journal-title":"Acta Diabetol"},{"key":"743_CR71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","volume":"114","author":"C Riehle","year":"2018","unstructured":"Riehle C, Bauersachs J (2018) Of mice and men: models and mechanisms of diabetic cardiomyopathy. Basic Res Cardiol 114:2. https:\/\/doi.org\/10.1007\/s00395-018-0711-0","journal-title":"Basic Res Cardiol"},{"key":"743_CR72","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00395-015-0476-7","volume":"110","author":"E Robinson","year":"2015","unstructured":"Robinson E, Cassidy RS, Tate M, Zhao Y, Lockhart S, Calderwood D, Church R, McGahon MK, Brazil DP, McDermott BJ, Green BD, Grieve DJ (2015) Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix. Basic Res Cardiol 110:20. https:\/\/doi.org\/10.1007\/s00395-015-0476-7","journal-title":"Basic Res Cardiol"},{"key":"743_CR73","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ijcard.2016.06.283","volume":"220","author":"ST Roos","year":"2016","unstructured":"Roos ST, Timmers L, Biesbroek PS, Nijveldt R, Kamp O, van Rossum AC, van Hout GP, Stella PR, Doevendans PA, Knaapen P, Velthuis BK, van Royen N, Voskuil M, Nap A, Appelman Y (2016) No benefit of additional treatment with exenatide in patients with an acute myocardial infarction. Int J Cardiol 220:809\u2013814. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.283","journal-title":"Int J Cardiol"},{"key":"743_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2018.18269","volume":"321","author":"J Rosenstock","year":"2019","unstructured":"Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK, Investigators CARMELITA (2019) Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial. JAMA 321:69\u201379. https:\/\/doi.org\/10.1001\/jama.2018.18269","journal-title":"JAMA"},{"key":"743_CR75","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.bbadis.2017.07.015","volume":"1864","author":"M Ruiz","year":"2018","unstructured":"Ruiz M, Coderre L, Allen BG, Des Rosiers C (2018) Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism. Biochim Biophys Acta Mol Basis Dis 1864:1914\u20131922. https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.015","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"743_CR76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.phrs.2015.02.003","volume":"94","author":"SM Salheen","year":"2015","unstructured":"Salheen SM, Panchapakesan U, Pollock CA, Woodman OL (2015) The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose. Pharmacol Res 94:26\u201333. https:\/\/doi.org\/10.1016\/j.phrs.2015.02.003","journal-title":"Pharmacol Res"},{"key":"743_CR77","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvt091","volume":"99","author":"O Sandanger","year":"2013","unstructured":"Sandanger O, Ranheim T, Vinge LE, Bliksoen M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G, Espevik T, Aukrust P, Yndestad A (2013) The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res 99:164\u2013174. https:\/\/doi.org\/10.1093\/cvr\/cvt091","journal-title":"Cardiovasc Res"},{"key":"743_CR78","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1536\/ihj.16-547","volume":"58","author":"A Sato","year":"2017","unstructured":"Sato A, Suzuki S, Watanabe S, Shimizu T, Nakamura Y, Misaka T, Yokokawa T, Shishido T, Saitoh SI, Ishida T, Kubota I, Takeishi Y (2017) DPP4 inhibition ameliorates cardiac function by blocking the cleavage of HMGB1 in diabetic mice after myocardial infarction. Int Heart J 58:778\u2013786. https:\/\/doi.org\/10.1536\/ihj.16-547","journal-title":"Int Heart J"},{"key":"743_CR79","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.imbio.2011.08.005","volume":"217","author":"M Satoh","year":"2012","unstructured":"Satoh M, Tabuchi T, Minami Y, Takahashi Y, Itoh T, Nakamura M (2012) Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal. Immunobiology 217:533\u2013539. https:\/\/doi.org\/10.1016\/j.imbio.2011.08.005","journal-title":"Immunobiology"},{"key":"743_CR80","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/s0008-6363(02)00319-x","volume":"55","author":"R Schulz","year":"2002","unstructured":"Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC, Heusch G (2002) p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 55:690\u2013700. https:\/\/doi.org\/10.1016\/s0008-6363(02)00319-x","journal-title":"Cardiovasc Res"},{"key":"743_CR81","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1096\/fj.02-0975fje","volume":"17","author":"R Schulz","year":"2003","unstructured":"Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, Heusch G (2003) Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 17:1355\u20131357. https:\/\/doi.org\/10.1096\/fj.02-0975fje","journal-title":"FASEB J"},{"key":"743_CR82","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"BM Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I, Committee S-TS, Investigators (2013) Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 369:1317\u20131326. https:\/\/doi.org\/10.1056\/NEJMoa1307684","journal-title":"N Engl J Med"},{"key":"743_CR83","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/CIRCULATIONAHA.104.495127","volume":"112","author":"R Scognamiglio","year":"2005","unstructured":"Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A (2005) Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 112:179\u2013184. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.495127","journal-title":"Circulation"},{"key":"743_CR84","doi-asserted-by":"publisher","first-page":"17529","DOI":"10.18632\/oncotarget.15420","volume":"8","author":"A Severino","year":"2017","unstructured":"Severino A, Zara C, Campioni M, Flego D, Angelini G, Pedicino D, Giglio AF, Trotta F, Giubilato S, Pazzano V, Lucci C, Iaconelli A, Ruggio A, Biasucci LM, Crea F, Liuzzo G (2017) Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4\u2009+\u2009T-lymphocytes in acute coronary syndromes. Oncotarget 8:17529\u201317550. https:\/\/doi.org\/10.18632\/oncotarget.15420","journal-title":"Oncotarget"},{"key":"743_CR85","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4\u201314. https:\/\/doi.org\/10.1016\/j.diabres.2009.10.007","journal-title":"Diabetes Res Clin Pract"},{"key":"743_CR86","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/ki.2015.103","volume":"88","author":"S Shi","year":"2015","unstructured":"Shi S, Srivastava SP, Kanasaki M, He J, Kitada M, Nagai T, Nitta K, Takagi S, Kanasaki K, Koya D (2015) Interactions of DPP-4 and integrin beta1 influences endothelial-to-mesenchymal transition. Kidney Int 88:479\u2013489. https:\/\/doi.org\/10.1038\/ki.2015.103","journal-title":"Kidney Int"},{"key":"743_CR87","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.00553.2014","volume":"309","author":"T Shinjo","year":"2015","unstructured":"Shinjo T, Nakatsu Y, Iwashita M, Sano T, Sakoda H, Ishihara H, Kushiyama A, Fujishiro M, Fukushima T, Tsuchiya Y, Kamata H, Nishimura F, Asano T (2015) DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-kappaB activation. Am J Physiol Endocrinol Metab 309:E214\u2013E223. https:\/\/doi.org\/10.1152\/ajpendo.00553.2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"743_CR88","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1001\/archinte.164.9.982","volume":"164","author":"I Stranders","year":"2004","unstructured":"Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164:982\u2013988. https:\/\/doi.org\/10.1001\/archinte.164.9.982","journal-title":"Arch Intern Med"},{"key":"743_CR89","doi-asserted-by":"publisher","first-page":"e0182422","DOI":"10.1371\/journal.pone.0182422","volume":"12","author":"M Suda","year":"2017","unstructured":"Suda M, Shimizu I, Yoshida Y, Hayashi Y, Ikegami R, Katsuumi G, Wakasugi T, Yoshida Y, Okuda S, Soga T, Minamino T (2017) Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2\/EGR-1 pathway. PLoS One 12:e0182422. https:\/\/doi.org\/10.1371\/journal.pone.0182422","journal-title":"PLoS One"},{"key":"743_CR90","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/FJC.0b013e31821e5626","volume":"58","author":"NN Ta","year":"2011","unstructured":"Ta NN, Schuyler CA, Li Y, Lopes-Virella MF, Huang Y (2011) DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 58:157\u2013166. https:\/\/doi.org\/10.1097\/FJC.0b013e31821e5626","journal-title":"J Cardiovasc Pharmacol"},{"key":"743_CR91","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3892\/etm.2018.6150","volume":"16","author":"X Tang","year":"2018","unstructured":"Tang X, Dai Y, Wang X, Zeng J, Li G (2018) MicroRNA-27a protects retinal pigment epithelial cells under high glucose conditions by targeting TLR4. Exp Ther Med 16:452\u2013458. https:\/\/doi.org\/10.3892\/etm.2018.6150","journal-title":"Exp Ther Med"},{"key":"743_CR92","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13062-017-0199-9","volume":"12","author":"X Tao","year":"2017","unstructured":"Tao X, Liu S, Men X, Xu Z (2017) Over-expression of miR-146b and its regulatory role in intestinal epithelial cell viability, proliferation, and apoptosis in piglets. Biol Direct 12:27. https:\/\/doi.org\/10.1186\/s13062-017-0199-9","journal-title":"Biol Direct"},{"key":"743_CR93","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jcp.10178","volume":"193","author":"G Thiel","year":"2002","unstructured":"Thiel G, Cibelli G (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193:287\u2013292. https:\/\/doi.org\/10.1002\/jcp.10178","journal-title":"J Cell Physiol"},{"key":"743_CR94","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17:179\u2013188. https:\/\/doi.org\/10.1038\/nm.2279","journal-title":"Nat Med"},{"key":"743_CR95","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejphar.2016.06.038","volume":"788","author":"A Wang","year":"2016","unstructured":"Wang A, Zhang H, Liang Z, Xu K, Qiu W, Tian Y, Guo H, Jia J, Xing E, Chen R, Xiang Z, Liu J (2016) U0126 attenuates ischemia\/reperfusion-induced apoptosis and autophagy in myocardium through MEK\/ERK\/EGR-1 pathway. Eur J Pharmacol 788:280\u2013285. https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.038","journal-title":"Eur J Pharmacol"},{"key":"743_CR96","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/aps.2016.72","volume":"37","author":"XW Wang","year":"2016","unstructured":"Wang XW, Zhang FX, Yang F, Ding ZF, Agarwal N, Guo ZK, Mehta JL (2016) Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro. Acta Pharmacol Sin 37:1349\u20131358. https:\/\/doi.org\/10.1038\/aps.2016.72","journal-title":"Acta Pharmacol Sin"},{"key":"743_CR97","doi-asserted-by":"publisher","first-page":"H1743","DOI":"10.1152\/ajpheart.01335.2008","volume":"300","author":"Y Wang","year":"2011","unstructured":"Wang Y, Zhang MX, Meng X, Liu FQ, Yu GS, Zhang C, Sun T, Wang XP, Li L, Wang YY, Ding SF, Yang JM, Zhang Y (2011) Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells. Am J Physiol Heart Circ Physiol 300:H1743\u2013H1752. https:\/\/doi.org\/10.1152\/ajpheart.01335.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"743_CR98","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00109-004-0600-x","volume":"83","author":"C Watala","year":"2005","unstructured":"Watala C, Pluta J, Golanski J, Rozalski M, Czyz M, Trojanowski Z, Drzewoski J (2005) Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. J Mol Med 83:148\u2013158. https:\/\/doi.org\/10.1007\/s00109-004-0600-x","journal-title":"J Mol Med"},{"key":"743_CR99","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Investig 115:1111\u20131119. https:\/\/doi.org\/10.1172\/JCI25102","journal-title":"J Clin Investig"},{"key":"743_CR100","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12:408\u2013415. https:\/\/doi.org\/10.1038\/ni.2022","journal-title":"Nat Immunol"},{"key":"743_CR101","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","volume":"369","author":"WB White","year":"2013","unstructured":"White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F, Investigators E (2013) Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 369:1327\u20131335. https:\/\/doi.org\/10.1056\/NEJMoa1305889","journal-title":"N Engl J Med"},{"key":"743_CR102","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00395-018-0674-1","volume":"113","author":"J Wider","year":"2018","unstructured":"Wider J, Undyala VVR, Whittaker P, Woods J, Chen X, Przyklenk K (2018) Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication. Basic Res Cardiol 113:16. https:\/\/doi.org\/10.1007\/s00395-018-0674-1","journal-title":"Basic Res Cardiol"},{"key":"743_CR103","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1479-5876-11-84","volume":"11","author":"P Wohlfart","year":"2013","unstructured":"Wohlfart P, Linz W, Hubschle T, Linz D, Huber J, Hess S, Crowther D, Werner U, Ruetten H (2013) Cardioprotective effects of lixisenatide in rat myocardial ischemia\u2013reperfusion injury studies. J Transl Med 11:84. https:\/\/doi.org\/10.1186\/1479-5876-11-84","journal-title":"J Transl Med"},{"key":"743_CR104","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.healun.2016.08.028","volume":"36","author":"Z Xu","year":"2017","unstructured":"Xu Z, Sharma M, Gelman A, Hachem R, Mohanakumar T (2017) Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation. J Heart Lung Transplant 36:331\u2013339. https:\/\/doi.org\/10.1016\/j.healun.2016.08.028","journal-title":"J Heart Lung Transplant"},{"key":"743_CR105","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","volume":"31","author":"Y Ye","year":"2017","unstructured":"Ye Y, Bajaj M, Yang HC, Perez-Polo JR, Birnbaum Y (2017) SGLT-2 inhibition with dapagliflozin reduces the activation of the Nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with saxagliptin, a DPP4 inhibitor. Cardiovasc Drugs Ther 31:119\u2013132. https:\/\/doi.org\/10.1007\/s10557-017-6725-2","journal-title":"Cardiovasc Drugs Ther"},{"key":"743_CR106","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/cvr\/cvq053","volume":"87","author":"Y Ye","year":"2010","unstructured":"Ye Y, Hu Z, Lin Y, Zhang C, Perez-Polo JR (2010) Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc Res 87:535\u2013544. https:\/\/doi.org\/10.1093\/cvr\/cvq053","journal-title":"Cardiovasc Res"},{"key":"743_CR107","doi-asserted-by":"publisher","first-page":"H1454","DOI":"10.1152\/ajpheart.00867.2009","volume":"298","author":"Y Ye","year":"2010","unstructured":"Ye Y, Keyes KT, Zhang C, Perez-Polo JR, Lin Y, Birnbaum Y (2010) The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. Am J Physiol Heart Circ Physiol 298:H1454\u2013H1465. https:\/\/doi.org\/10.1152\/ajpheart.00867.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"743_CR108","doi-asserted-by":"publisher","first-page":"H2436","DOI":"10.1152\/ajpheart.00690.2008","volume":"295","author":"Y Ye","year":"2008","unstructured":"Ye Y, Lin Y, Manickavasagam S, Perez-Polo JR, Tieu BC, Birnbaum Y (2008) Pioglitazone protects the myocardium against ischemia\u2013reperfusion injury in eNOS and iNOS knockout mice. Am J Physiol Heart Circ Physiol 295:H2436\u2013H2446. https:\/\/doi.org\/10.1152\/ajpheart.00690.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"743_CR109","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00395-011-0216-6","volume":"106","author":"Y Ye","year":"2011","unstructured":"Ye Y, Perez-Polo JR, Aguilar D, Birnbaum Y (2011) The potential effects of anti-diabetic medications on myocardial ischemia\u2013reperfusion injury. Basic Res Cardiol 106:925\u2013952. https:\/\/doi.org\/10.1007\/s00395-011-0216-6","journal-title":"Basic Res Cardiol"},{"key":"743_CR110","doi-asserted-by":"publisher","first-page":"H131","DOI":"10.1152\/ajpheart.00609.2012","volume":"304","author":"Y Ye","year":"2013","unstructured":"Ye Y, Qian J, Castillo AC, Ling S, Ye H, Perez-Polo JR, Bajaj M, Birnbaum Y (2013) Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes. Am J Physiol Heart Circ Physiol 304:H131\u2013H141. https:\/\/doi.org\/10.1152\/ajpheart.00609.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"743_CR111","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/1074248414524482","volume":"19","author":"AH Yoon","year":"2014","unstructured":"Yoon AH, Ye Y, Birnbaum Y (2014) Dipeptidyl peptidase IV inhibitors and ischemic myocardial injury. J Cardiovasc Pharmacol Ther 19:417\u2013425. https:\/\/doi.org\/10.1177\/1074248414524482","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"743_CR112","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1210\/en.2011-1326","volume":"152","author":"YH Youm","year":"2011","unstructured":"Youm YH, Adijiang A, Vandanmagsar B, Burk D, Ravussin A, Dixit VD (2011) Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 152:4039\u20134045. https:\/\/doi.org\/10.1210\/en.2011-1326","journal-title":"Endocrinology"},{"key":"743_CR113","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1475-2840-13-32","volume":"13","author":"Y Zeng","year":"2014","unstructured":"Zeng Y, Li C, Guan M, Zheng Z, Li J, Xu W, Wang L, He F, Xue Y (2014) The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms. Cardiovasc Diabetol 13:32. https:\/\/doi.org\/10.1186\/1475-2840-13-32","journal-title":"Cardiovasc Diabetol"},{"key":"743_CR114","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00395-008-0725-0","volume":"103","author":"C Zhang","year":"2008","unstructured":"Zhang C, Park Y, Picchi A, Potter BJ (2008) Maturation-induces endothelial dysfunction via vascular inflammation in diabetic mice. Basic Res Cardiol 103:407\u2013416. https:\/\/doi.org\/10.1007\/s00395-008-0725-0","journal-title":"Basic Res Cardiol"},{"key":"743_CR115","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.1074\/jbc.C000917200","volume":"276","author":"H Zhang","year":"2001","unstructured":"Zhang H, Shi X, Hampong M, Blanis L, Pelech S (2001) Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J Biol Chem 276:6905\u20136908. https:\/\/doi.org\/10.1074\/jbc.C000917200","journal-title":"J Biol Chem"},{"key":"743_CR116","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejphar.2016.10.016","volume":"791","author":"F Zhou","year":"2016","unstructured":"Zhou F, Zhang Y, Chen J, Hu X, Xu Y (2016) Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice. Eur J Pharmacol 791:735\u2013740. https:\/\/doi.org\/10.1016\/j.ejphar.2016.10.016","journal-title":"Eur J Pharmacol"},{"key":"743_CR117","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/cmi.2011.19","volume":"8","author":"R Zhou","year":"2011","unstructured":"Zhou R, O\u2019Hara SP, Chen XM (2011) MicroRNA regulation of innate immune responses in epithelial cells. Cell Mol Immunol 8:371\u2013379. https:\/\/doi.org\/10.1038\/cmi.2011.19","journal-title":"Cell Mol Immunol"},{"key":"743_CR118","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.bbrc.2018.09.134","volume":"505","author":"W Zhu","year":"2018","unstructured":"Zhu W, Feng PP, He K, Li SW, Gong JP (2018) Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet. Biochem Biophys Res Commun 505:523\u2013529. https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.134","journal-title":"Biochem Biophys Res Commun"},{"key":"743_CR119","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.2337\/db16-0317","volume":"65","author":"F Zhuge","year":"2016","unstructured":"Zhuge F, Ni Y, Nagashimada M, Nagata N, Xu L, Mukaida N, Kaneko S, Ota T (2016) DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1\/M2 macrophage polarization. Diabetes 65:2966\u20132979. https:\/\/doi.org\/10.2337\/db16-0317","journal-title":"Diabetes"},{"key":"743_CR120","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4239\/wjd.v9.i9.149","volume":"9","author":"VA Zykov","year":"2018","unstructured":"Zykov VA, Tuchina TP, Lebedev DA, Krylova IB, Babenko AY, Kuleshova EV, Grineva EN, Bayramov AA, Galagudza MM (2018) Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus. World J Diabetes 9:149\u2013156. https:\/\/doi.org\/10.4239\/wjd.v9.i9.149","journal-title":"World J Diabetes"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-019-0743-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-019-0743-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-019-0743-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T10:03:46Z","timestamp":1644919426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-019-0743-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":120,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["743"],"URL":"https:\/\/doi.org\/10.1007\/s00395-019-0743-0","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Ye received research grants from Astra Zeneca and Boehringer Ingelheim. Dr. Bajaj received research grants from AstraZeneca, Boehringer Ingelheim, Eli-Lilly, Sanofi Aventis, and Novo Nordisk. Dr. Birnbaum receives research grants from Astra Zeneca. Dr. Tran has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"35"}}